2024

Août 2024
 « French protocol for the diagnosis and management of systemic lupus erythematosus ».
Amoura Z, Bader-Meunier B, Antignac M, Bardin N, Belizna C, Belot A, Bonnotte B, Bouaziz JD, Chasset F, Chiche L, Cohen F, Costedoat-Chalumeau N, Daugas E, Devilliers H, Diot E, Elefant E, Faguer S, Ferreira N, Hachulla E, Hanslik T, Hie M, Jourde-Chiche N, Le Guern V, Martin T, Mathian A, Michel M, Miyara M, Papo T, Richez C, Scherlinger M, Sibilia J, Uzunhan Y, Wahl D, Wojtasik G, Yelnik C; Collaborators; Collaborators.
Rev Med Interne. 2024 Aug 26:S0248-8663(24)00708-2. doi: 10.1016/j.revmed.2024.07.006. Epub ahead of print. PMID: 39191627.
PMID: 39191627  DOI: 10.1016/j.revmed.2024.07.006

« Transcriptomic analysis of one patient with lupus skin lesions treated with anifrolumab ». Grolleau C, Poisot T, Hadjadj J, Jachiet M, Mahevas T, Le Buanec H, Bouaziz JD, Chasset F.
J Eur Acad Dermatol Venereol. 2024 Aug 13. doi: 10.1111/jdv.20283. Epub ahead of print. PMID: 39136527.
PMID: 39136527 DOI: 10.1111/jdv.20283

Juillet 2024
« Risk of flare in patients with SLE in remission after hydroxychloroquine or chloroquine withdrawal ».
Trefond L, Mathian A, Lhote R, De Chambrun MP, Pha M, Hie M, Miyara M, Papo M, Moyon Q, Taieb D, Ait Abdallah N, Chasset F, Aubart FC, Haroche J, Zahr N, Amoura Z.
Joint Bone Spine. 2024 Jul 2;91(6):105756. doi: 10.1016/j.jbspin.2024.105756. Epub ahead of print. PMID: 38964624.
PMID: 38964624  DOI: 10.1016/j.jbspin.2024.105756

Juin 2024
« Identification of new risk factors for hydroxychloroquine and chloroquine retinopathy in systemic lupus erythematosus patients »
Trefond L, Lhote R, Mathian A, de Chambrun MP, Pha M, Hie M, Miyara M, Papo M, Moyon Q, Taieb D, Saade S, Salem TB, Haroche J, Chasset F, Aubart FC, Zahr N, Amoura Z.
Semin Arthritis Rheum. 2024 Jun;66:152417. doi: 10.1016/j.semarthrit.2024.152417. Epub
2024 Feb 12. PMID: 38394986.
https://doi.org/10.1016/j.semarthrit.2024.152417
PMID : 38394986 DOI : 10.1016/j.semarthrit.2024.152417
5

14 mars 2024
« Recent findings about antimalarials incutaneous lupus erythematosus: What dermatologists should know. »
Teboul A, Arnaud L, Chasset F.
J Dermatol. 2024 Mar 14. doi: 10.1111/1346-8138.17177. Epub ahead of print. PMID: 38482997.
https://doi.org/10.1111/1346-8138.17177
PMID : 38482997 DOI : 10.1111/1346-8138.17177
2

07 mars 2024
« International exchange on the clinical practice and research of rheumatic skin diseases: A report of the 5th International Conference of Cutaneous Lupus Erythematosus »
Hasegawa M, Chasset F, Chong BF, Fiorentino DF, Fujimoto M, Nyberg F, Sato S, Wenzel J, Werth VP.
J Dermatol. 2024 Mar 7. doi: 10.1111/1346-8138.17153. Epub ahead of print. PMID: 38450816.
https://doi.org/10.1111/1346-8138.17153
PMID: 38450816 DOI: 10.1111/1346-8138.17153
4

15 février 2024
« Clinical trial outcomes for SLE: what we have and what we need ».
Arnaud L, Parodis I, Devilliers H, Chasset F.
Lupus Sci Med. 2024 Feb 15;11(1):e001114. doi: 10.1136/lupus-2023-001114. PMID: 38360028; PMCID: PMC10875561
http://www.ncbi.nlm.nih.gov/pmc/articles/pmc10875561/
https://doi.org/10.1136/lupus-2023-001114
PMID: 38360028 PMCID: PMC10875561 DOI: 10.1136/lupus-2023-001114
6

12 mars 2024
« Low plasma belimumab levels as an indicator of poor adherence to belimumab in patients with systemic lupus erythematosus.»
Trefond L, Zahr N, Lhote R, Pha M, Hié M, Miyara M, Papo M, Moyon Q, Hausfater P, Chasset F, Haroche J, Cohen-Aubart F, Mathian A, Amoura Z.
Ann Rheum Dis. 2024 Mar 12;83(4):541-543. doi: 10.1136/ard-2023-225023. PMID: 38123937.
https://doi.org/10.1136/ard-2023-225023
PMID : 38123937 DOI : 10.1136/ard-2023-225023
8

1^er Février 2024
« Comparison of patients with isolated cutaneous lupus erythematosus versus systemic lupus erythematosus with cutaneous lupus erythematosus as the sole clinical feature: A monocentric study of 149 patients. »
Masseran C, Perray L, Murat de Montai Q, Mathian A, Teboul A, Francès C, Arnaud L, Costedoat-Chalumeau N, Amoura Z, Courvoisier DS, Barbaud A, Chasset F.
J Am Acad Dermatol. 2024 Jun;90(6):1210-1217. doi: 10.1016/j.jaad.2024.01.041. Epub 2024 Feb 1. PMID: 38301924.
https://doi.org/10.1016/j.jaad.2024.01.041
PMID : 38301924 DOI : 10.1016/j.jaad.2024.01.041
7

2023

10 octobre 2023
« Prevalence, characteristics, and knowledge related to photosensitivity in patients with lupus erythematosus: the international PHOTOLUP study.»
Battesti G, Felten R, Piga M, Sarmiento-Monroy JC, Ziade N, El Kibbi L, Ugarte-Gil M, Arnaud L, Chasset F.
Rheumatology (Oxford). 2023 Oct 10:kead548. doi: 10.1093/rheumatology/kead548. Epub ahead of print. PMID: 37815827.
https://doi.org/10.1093/rheumatology/kead548
PMID: 37815827 DOI: 10.1093/rheumatology/kead548
12
 
Octobre 2023
« Risk factors of progression from discoid lupus to severe systemic lupus erythematosus: More evidence will be needed: Authors reply. »
Fredeau L, Courvoisier D, Chasset F.
J Am Acad Dermatol. 2023 Oct;89(4):e165-e166. doi: 10.1016/j.jaad.2023.05.056. Epub 2023 Jun 2. PMID: 37269923.
https://doi.org/10.1016/j.jaad.2023.05.056
PMID : 37269923 DOI : 10.1016/j.jaad.2023.05.056
21

Juillet 2023
« Rapid efficacy of anifrolumab in refractory cutaneous lupus
erythematosus. »
Chasset F, Jaume L, Mathian A, Abisror N, Dutheil A, Barbaud A, Kottler D,
Girard C, Jousse-Joulin S, Tauber M, Livideanu CB, Avettand-Fenoel V, Lhote R, Pha M, Amoura Z. EMSED (Etude des maladies systémiques en dermatologie) study group.
J Am Acad Dermatol. 2023 Jul;89(1):171-173. doi: 10.1016/j.jaad.2023.02.044. Epub 2023 Mar 5. PMID: 36878316.
https://doi.org/10.1016/j.jaad.2023.02.044
PMID : 36878316 DOI : 10.1016/j.jaad.2023.02.044
24

Juillet 2023
“Characteristics of cutaneous lupus erythematosus in Black patients, association with systemic lupus and response to treatment: A retrospective cohort study of 141 patients. »
Jaume L, Fayard D, Breillat P, Francès C, Dutheil A, Barbaud A, Arnaud L, Mathian A, Amoura Z, Chasset F.
J Eur Acad Dermatol Venereol. 2023 Jul;37(7):e868-e871. doi: 10.1111/jdv.18966. Epub 2023 Feb 25. PMID: 36786356.
https://doi.org/10.1111/jdv.18966
PMID : 36786356 DOI : 10.1111/jdv.18966
25
 
1^er juin 2023
« Cutaneous vasculitis occurring in the setting of systemic lupus erythematosus: a multicentre cohort study. »
Breillat P, Jachiet M, Ditchi Y, Lenormand C, Costedoat-Chalumeau N, Mathian A, Moguelet P, Duriez P, Trendelenburg M, Huynh-Do U, Chizzolini C, Beuvon C, Roy-Peaud F, Bouaziz JD, Barbaud A, Francès C, Mékinian A, Fain O, Amoura Z, Chasset F; for EMSED study group (Etude des maladies systémiques en dermatologie) and the Swiss SLE Cohort Study (SSCS).
Rheumatology (Oxford). 2023 Jun 1;62(6):2189-2196. doi:10.1093/rheumatology/keac566. PMID: 36190335.
https://doi.org/10.1093/rheumatology/keac566
PMID: 36190335 DOI: 10.1093/rheumatology/keac566
31

Mars 2023
« Is there an increased risk of severe COVID-19 among patients with systemic
lupus erythematosus treated with anifrolumab? » Lupus
Breillat P, Mathian A, Rozenberg F, Dutheil A, Barbaud A, Amoura Z, Chasset F.
2023 Mar;32(3):453-455. doi: 10.1177/09612033231153536. Epub 2023 Jan 19. PMID: 36659863; PMCID:
PMC9895280.
https://doi.org/10.1177/09612033231153536
http://www.ncbi.nlm.nih.gov/pmc/articles/pmc9895280/
PMID: 36659863 PMCID: PMC9895280 DOI: 10.1177/09612033231153536
26

Mars 2023
« New biologics and targeted therapies in systemic lupus: From new molecular targets to new
indications. A systematic review. »
Felten R, Scherlinger M, Mertz P, Chasset F, Arnaud L.
Joint Bone Spine. 2023 Mar;90(2):105523. doi: 10.1016/j.jbspin.2023.105523. Epub 2023 Jan 7. PMID: 36623799
https://doi.org/10.1016/j.jbspin.2023.105523
PMID: 36623799 DOI: 10.1016/j.jbspin.2023.105523
27

Mars 2023
« Risk factors of progression from discoid lupus to severe systemic lupus erythematosus: a registry-based cohort study of 164 patients. »
Fredeau L, Courvoisier DS, Ait Mehdi R, Ingen-Housz-Oro S, Mahe E, Costedoat-Chalumeau N, Arnaud L, Francès C, Mathian A, Jachiet M, Amoura Z, Bouaziz JD, Chasset F; EMSED study group.
J Am Acad Dermatol. 2023 Mar;88(3):551-559. doi:10.1016/j.jaad.2022.09.028. Epub 2022 Sep 23. PMID: 36156304.
https://doi.org/10.1016/j.jaad.2022.09.028
PMID: 36156304 DOI: 10.1016/j.jaad.2022.09.028
32

2022

Décembre 2022
« Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies neutralising IFN-α. »
Mathian A, Breillat P, Dorgham K, Bastard P, Charre C, Lhote R, Quentric P, Moyon Q, Mariaggi AA, Mouries-Martin S, Mellot C, Anna F, Haroche J, Cohen- Aubart F, Sterlin D, Zahr N, Gervais A, Le Voyer T, Bizien L, Amiot Q, Pha M, Hié M, Chasset F, Yssel H, Miyara M, Charneau P, Ghillani-Dalbin P, Casanova JL, Rozenberg F, Amoura Z, Gorochov G.
Ann Rheum Dis. 2022 Dec;81(12):1695-1703. doi: 10.1136/ard-2022-222549. Epub 2022 Aug 16. PMID: 35973806.
https://doi.org/10.1136/ard-2022-222549
PMID: 35973806 DOI: 10.1136/ard-2022-222549
35

Décembre 2022
« The history of lupus throughout the ages. »
Felten R, Lipsker D, Sibilia J, Chasset F, Arnaud L.
J Am Acad Dermatol. 2022 Dec;87(6):1361-1369. doi: 10.1016/j.jaad.2020.04.150. Epub 2020 May 4. PMID: 32380218.
https://doi.org/10.1016/j.jaad.2020.04.150
PMID: 32380218 DOI: 10.1016/j.jaad.2020.04.150
84

2 Novembre 2022
« Clonal haematopoiesis of indeterminate potential and cardiovascular events in systemic
lupus erythematosus (HEMATOPLUS study). »
David C, Duployez N, Eloy P, Belhadi D, Chezel J, Guern VL, Laouénan C, Fenwarth L, Rouzaud D, Mathian A, de Almeida Chaves S, Duhaut P, Fain O, Galicier L, Ghillani-Dalbin P, Kahn JE, Morel N, Perard L, Pha M, Sarrot- Reynauld F, Aumaitre O, Chasset F, Limal N, Desmurs-Clavel H, Ackermann F,
Amoura Z, Papo T, Preudhomme C, Costedoat-Chalumeau N, Sacre K.
Rheumatology (Oxford). 2022 Nov 2;61(11):4355-4363. doi: 10.1093/rheumatology/keac108. PMID: 35176141.
https://doi.org/10.1093/rheumatology/keac108
PMID: 35176141 DOI: 10.1093/rheumatology/keac108
42

1^er octobre 2022
« Proton Pump Inhibitors Associated With Drug-Induced Lupus Erythematosus. »
Bataille P, Lebrun-Vignes B, Tubach F, Aroux-Pavard M, Philibert C, Chasset F, Barbaud A.
JAMA Dermatol. 2022 Oct 1;158(10):1208-1210. doi:10.1001/jamadermatol.2022.2421. PMID: 35976639; PMCID: PMC9386607.
https://doi.org/10.1001/jamadermatol.2022.2421
http://www.ncbi.nlm.nih.gov/pmc/articles/pmc9386607/
PMID: 35976639 PMCID: PMC9386607  DOI: 10.1001/jamadermatol.2022.2421
34

Septembre 2022
« Soluble CD163 and incident cardiovascular events in patients with systemic lupus erythematosus: An observational cohort study. »
David C, Costedoat-Chalumeau N, Belhadi D, Laouénan C, Boutten A, Chezel J, Rouzaud D, Dehoux M, Guern VL, Mathian A, Chaves SA, Duhaut P, Fain O, Galicier L, Ghillani-Dalbin P, Kahn JE, Morel N, Perard L, Pha M, Sarrot-Reynauld F, Aumaitre O, Chasset F, Limal N, Desmurs-Clavel H, Ackermann F, Amoura Z, Papo T, Sacre K.
J Intern Med. 2022 Sep;292(3):536-539. doi: 10.1111/joim.13490. Epub 2022 Apr 10. PMID: 35373869; PMCID: PMC9542031.
https://doi.org/10.1111/joim.13490
http://www.ncbi.nlm.nih.gov/pmc/articles/pmc9542031/
PMID: 35373869 PMCID: PMC9542031 DOI: 10.1111/joim.13490
40

Aout 2022
« Prevalence and factors associated with long-term remission in cutaneous lupus: A longitudinal cohort study of 141 cases. »
Fayard D, Francès C, Amoura Z, Breillat P, Mathian A, Senet P, Barbaud A, Arnaud L, Chasset F.
J Am Acad Dermatol. 2022 Aug;87(2):323-332. doi: 10.1016/j.jaad.2022.03.056. Epub 2022 Apr
PMID: 35390427.
https://doi.org/10.1016/j.jaad.2022.03.056
PMID: 35390427 DOI: 10.1016/j.jaad.2022.03.056
39

Juillet 2022
« Male sex, discoid lupus erythematosus, and lower limb involvement are associated with systemic lupus in lupus panniculitis patients: A multicenter case series of 74 patients. »
Lemasson J, Frumholtz L, Jachiet M, Lenormand C, Lipsker D, Moulin S, Chiaverini C, Le Duff F, Passeron T, Cordoliani F, Bagot M, Monfort JB, Senet P, De Masson A, Cassius C, Petit A, Misery L, Moguelet P, Cordel N, Fardet L, Begon E, Frances C, Bessis D, Bouaziz JD, Chasset F.
J Am Acad Dermatol. 2022 Jul;87(1):219-221. doi: 10.1016/j.jaad.2021.07.052. Epub 2021 Aug 2. PMID: 34352346.
https://doi.org/10.1016/j.jaad.2021.07.052
PMID: 34352346  DOI: 10.1016/j.jaad.2021.07.052
58

Juillet 2022
« Hydroxychloroquine dose,tapering or discontinuation in cutaneous lupus erythematosus after remission: A retrospective multicenter cohort study of 56 patients. »
Sonigo G, Jachiet M, Bessis D, Cordel N, Faucon C, Petit A, Cordoliani F, Bagot M, Senet P, Barbaud A, Bouaziz JD, Francès C, Chasset F; EMSED study group (Etudes des Maladies Systémiques en Dermatologie).
J Am Acad Dermatol. 2022 Jul;87(1):203-206. doi: 10.1016/j.jaad.2021.07.038. Epub 2021 Jul 30. PMID: 34333080.
https://doi.org/10.1016/j.jaad.2021.07.038
PMID: 34333080 DOI: 10.1016/j.jaad.2021.07.038
59

Juin 2022
« Physician Global Assessment International Standardisation Consensus in Systemic Lupus Erythematosus: the PISCOS study. »
Piga M, Chessa E, Morand EF, Ugarte-Gil MF, Tektonidou M, van Vollenhoven R, Petri M, Arnaud L; PISCOS Investigator Group.
Lancet Rheumatol. 2022 Jun;4(6):e441-e449. doi: 10.1016/S2665-9913(22)00107-2. Epub 2022 May 4. PMID: 38293958.
https://doi.org/10.1016/s2665-9913(22)00107-2
PMID: 38293958 DOI: 10.1016/S2665-9913(22)00107-2
37
 
Juin 2022
« Unusual severe radiation-induced toxicity in a patient with discoid lupus erythematosus: A case report and critical review of the literature. »
Allali S, Chasset F, Kirova Y, Saint-Martin C, Moguelet P, Fourquet A, Beddok A. Cancer Radiother. 2022 Jun;26(4):594-598. doi: 10.1016/j.canrad.2021.07.039. Epub 2021 Oct 30. PMID: 34728115.
https://doi.org/10.1016/j.canrad.2021.07.039
PMID: 34728115 DOI: 10.1016/j.canrad.2021.07.039
49

Juin 2022
« Serum interferon-α levels and IFN type I-stimulated genes score perform equally to assess systemic lupus erythematosus disease activity »
Chasset F, Mathian A, Dorgham K, Ribi C, Trendelenburg M, Huynh-Do U, Roux-Lombard P, Courvoisier DS, Amoura Z, Gorochov G, Chizzolini C.
Ann Rheum Dis. 2022 Jun;81(6):901-903. doi: 10.1136/annrheumdis-2021-221835. Epub 2022 Jan 28. PMID: 35091421.
https://doi.org/10.1136/annrheumdis-2021-221835
PMID: 35091421 DOI: 10.1136/annrheumdis-2021-221835
43

Mai 2022
« Acropulpitis in systemic lupus erythematosus is associated with high type 1 interferon signature. »
Sonigo G, Cassius C, Battistella M, Le Buanec H, Bagot M, Saussine A, de Masson A, Lehmann-Che J, Chasset F, Jachiet M, Bouaziz JD.
Exp Dermatol. 2022 May;31(5):819-820. doi: 10.1111/exd.14485. Epub 2021 Nov 6. PMID: 34699626.
https://doi.org/10.1111/exd.14485
PMID: 34699626 DOI: 10.1111/exd.14485
52

Avril 2022
« Clinical efficacy of selective JAK1 inhibition and transcriptome analysis of chronic discoid lupus erythematosus. »
Calugareanu A, Grolleau C, Le Buanec H, Chasset F, Jachiet M, Battistella M, Bagot M, Jullien D, Poutrel S, Bouaziz JD, Ben Said B.
J Eur Acad Dermatol Venereol. 2022 Apr;36(4):e308-e310. doi: 10.1111/jdv.17839. Epub 2021 Dec 27. PMID: 34839559.
https://doi.org/10.1111/jdv.17839
PMID: 34839559 DOI: 10.1111/jdv.17839
47

Février 2022
« Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge. »
Dima A, Jurcut C, Chasset F, Felten R, Arnaud L.
Ther Adv Musculoskelet Dis. 2022 Feb 14;14:1759720X211073001. doi: 10.1177/1759720X211073001. PMID: 35186126; PMCID: PMC8848057.
https://doi.org/10.1177/1759720×211073001
http://www.ncbi.nlm.nih.gov/pmc/articles/pmc8848057/
PMID: 35186126 PMCID: PMC8848057  DOI: 10.1177/1759720X211073001
41

2021

Décembre 2021
 « Cutaneous drug-induced lupus erythematosus: Clinical and immunological characteristics and update on new associated drugs. »
Bataille P, Chasset F, Monfort JB, De Risi-Pugliese T, Soria A, Francès C, Barbaud A, Senet P.
Ann Dermatol Venereol. 2021 Dec;148(4):211-220. doi: 10.1016/j.annder.2021.02.006. Epub 2021
Oct 26. PMID: 34711400.
https://doi.org/10.1016/j.annder.2021.02.006
PMID: 34711400 DOI: 10.1016/j.annder.2021.02.006
51

Aout 2021
« Clinical characteristics of itch in cutaneous lupus erythematosus: A prospective, multicenter, multinational, cross-sectional study. »
Samotij D, Szczęch J, Antiga E, Bonciani D, Caproni M, Chasset F, Dańczak- Pazdrowska A, Furukawa F, Hasegawa M, Hashizume H, Ikeda T, Islam A, Kim HJ, Lesiak A, Misery L, Mowla MR, Polańska A, Szepietowski JC, Tsuruta D, Verdelli A, Werth VP, Reich A.
Lupus. 2021 Aug;30(9):1385-1393. doi: 10.1177/09612033211016098. Epub 2021 May 18. PMID: 34000879.
https://doi.org/10.1177/09612033211016098
PMID: 34000879 DOI: 10.1177/09612033211016098
63

Juillet 2021
« Nailfold capillaroscopy findings in cutaneous lupus erythematosus patients with or without digital lesions and comparison with dermatomyositis patients: A prospective study. »
Monfort JB, Chasset F, Barbaud A, Frances C, Senet P.
Lupus. 2021 Jul;30(8):1207-1213. doi: 10.1177/09612033211010329. Epub 2021 Apr 15. PMID: 33853419.
https://doi.org/10.1177/09612033211010329
PMID: 33853419 DOI: 10.1177/09612033211010329
66

Avril 2021
« Long-term efficacy and safety outcomes of lenalidomide for cutaneous lupus erythematosus: A multicenter retrospective observational study of 40 patients. »
Aitmehdi R, Arnaud L, Francès C, Senet P, Monfort JB, de Risi-Pugliese T, Barbaud A, Cohen-Aubart F, Haroche J, Pha M, Hie M, Le Guern V, Costedoat- Chalumeau N, Mékinian A, Fain O, Mathian A, Amoura Z, Chasset F.
J Am Acad Dermatol. 2021 Apr;84(4):1171-1174. doi: 10.1016/j.jaad.2020.11.014. Epub 2020 Nov 19. PMID: 33221461.
https://doi.org/10.1016/j.jaad.2020.11.014
PMID: 33221461 DOI: 10.1016/j.jaad.2020.11.014
72

Mars 2021
« Cutaneous Kikuchi disease-like inflammatory pattern without lymph node involvement is associated with systemic disease and severe features in lupus erythematous: A case-control study. »
Lalevée S, Moguelet P, Hurabielle C, Senet P, Pha M, Rivière S, Barbaud A, Amoura Z, Francès C, Chasset F.
Lupus. 2021 Mar;30(3):473-477. doi: 10.1177/0961203320978519. Epub 2020 Dec 8. PMID: 33292039.
https://doi.org/10.1177/0961203320978519
PMID: 33292039 DOI: 10.1177/0961203320978519
69

Mars 2021
« Highly sensitive serum cardiac troponin T and
cardiovascular events in patients with systemic lupus erythematosus (TROPOPLUS study). »
Chezel J, Costedoat-Chalumeau N, Laouénan C, Rouzaud D, Chenevier-Gobeaux C, Le Guern V, Mathian A, Belhadi D, de Almeida Chaves S, Duhaut P, Fain O, Galicier L, Ghillani-Dalbin P, Kahn JE, Morel N, Perard L, Pha M, Saidoune F, Sarrot-Reynauld F, Aumaitre O, Chasset F, Limal N, Desmurs-Clavel H, Ackermann F, Amoura Z, Papo T, Sacre K.
Rheumatology (Oxford). 2021 Mar 2;60(3):1210-1215. doi: 10.1093/rheumatology/keaa434. PMID: 32901293.
https://doi.org/10.1093/rheumatology/keaa434
PMID: 32901293 DOI: 10.1093/rheumatology/keaa434
77

Janvier 2021
« Characterization of drug-induced cutaneous lupus: Analysis of 1994 cases using the WHO pharmacovigilance database. »
Kawka L, Mertz P, Chasset F, Lebrun-Vignes B, Salem JE, Arnaud L. Autoimmun Rev. 2021 Jan;20(1):102705. doi: 10.1016/j.autrev.2020.102705. Epub 2020 Nov 11. PMID: 33188917.
https://doi.org/10.1016/j.autrev.2020.102705
PMID: 33188917 DOI: 10.1016/j.autrev.2020.102705
73

2020

Décembre 2020
« Lupus érythémateux et atteinte unguéale : étude rétrospective sur 14 patients [Ungual lesions in lupus erythematosus: A retrospective study of 14 patients]. »
Wagner C, Chasset F, Francès C, Lipsker D.
Ann Dermatol Venereol. 2020 Dec;147(12):823-832. French. doi: 10.1016/j.annder.2020.06.015. Epub 2020 Aug 3. PMID: 32763004.
https://doi.org/10.1016/j.annder.2020.06.015
PMID: 32763004 DOI: 10.1016/j.annder.2020.06.015
78

Décembre 2020
« Risk factors for hydroxychloroquine retinopathy in systemic lupus erythematosus: a case-control study with hydroxychloroquine blood-level analysis »
Lenfant T, Salah S, Leroux G, Bousquet E, Le Guern V, Chasset F, Francès C, Morel N, Chezel J, Papo T, Cacoub P, Mouthon L, Guettrot-Imbert G, Cohen P, Régent A, Mauget-Faÿsse M, Piette JC, Jallouli M, Costedoat-Chalumeau N; PLUS Group.
Rheumatology (Oxford). 2020 Dec 1;59(12):3807-3816. doi: 10.1093/rheumatology/keaa157. PMID: 32442312; PMCID: PMC8186841.
https://doi.org/10.1093/rheumatology/keaa157
http://www.ncbi.nlm.nih.gov/pmc/articles/pmc8186841/
PMID: 32442312 PMCID: PMC8186841 DOI: 10.1093/rheumatology/keaa157
81

Décembre 2020
« Belimumab for refractory manifestations of cutaneous lupus: A multicenter, retrospective observational study of 16 patients. »
Salle R, Chasset F, Kottler D, Picard-Dahan C, Jannic A, Mekki N, De Risi-Pugliese T, Monfort JB, Barbaud A, Francès C, Descamps V.
J Am Acad Dermatol. 2020 Dec;83(6):1816-1819. doi: 10.1016/j.jaad.2020.05.058. Epub 2020 May 19. PMID: 32439463.
https://doi.org/10.1016/j.jaad.2020.05.058
PMID: 32439463 DOI: 10.1016/j.jaad.2020.05.058
82

Novembre 2020
« Identification of highly active systemic lupus erythematosus by combined type I interferon and neutrophil gene scores vs classical serologic markers. »
Chasset F, Ribi C, Trendelenburg M, Huynh-Do U, Roux-Lombard P, Courvoisier DS, Chizzolini C; Swiss SLE Cohort Study (SSCS.
Rheumatology (Oxford). 2020 Nov 1;59(11):3468-3478. doi: 10.1093/rheumatology/keaa167. PMID: 32375176.
https://doi.org/10.1093/rheumatology/keaa167
PMID: 32375176 DOI: 10.1093/rheumatology/keaa167
85

Septembre 2020
« Hydroxychloroquine levels in patients with systemic lupus erythematosus: whole blood is preferable but serum levels also detect non-adherence. »
76: Blanchet B, Jallouli M, Allard M, Ghillani-Dalbin P, Galicier L, Aumaître O, Chasset F, Le Guern V, Lioté F, Smail A, Limal N, Perard L, Desmurs-Clavel H, Le Thi Huong D, Asli B, Kahn JE, Sailler L, Ackermann F, Papo T, Sacré K, Fain O, Stirnemann J, Cacoub P, Leroux G, Cohen-Bittan J, Sellam J, Mariette X, Goulvestre C, Hulot JS, Amoura Z, Vidal M, Piette JC; PLUS Group; Jourde-Chiche
N, Costedoat-Chalumeau N.
Arthritis Res Ther. 2020 Sep 25;22(1):223. doi:10.1186/s13075-020-02291-z. PMID: 32977856; PMCID: PMC7517694.
https://doi.org/10.1186/s13075-020-02291-z
http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7517694/
PMID: 32977856 PMCID: PMC7517694 DOI: 10.1186/s13075-020-02291-z
76

Mai 2020
« Discoid drug-induced lupus erythematosus induced by antitumor necrosis factor agents is a very rare subtype of cutaneous lupus: Three cases and literature review. »
Brehon A, Moguelet P, Guégan S, Abisror N, Barbaud A, Beal C, Laffitte E, Fain O, Francès C, Chasset F.
Dermatol Ther. 2020 May;33(3):e13364. doi:10.1111/dth.13364. Epub 2020 Apr 20. PMID: 32239589.
https://doi.org/10.1111/dth.13364
PMID: 32239589 DOI: 10.1111/dth.13364
88

Janvier 2020
« Lupus érythémateux et atteinte unguéale : revue de la littérature [Ungual lesions in lupus erythematosus: A literature review]. »
Wagner C, Chasset F, Fabacher T, Lipsker D.
Ann Dermatol Venereol. 2020 Jan;147(1):18-28. French. doi: 10.1016/j.annder.2019.10.027. Epub 2019 Dec 4. PMID: 31812364
https://doi.org/10.1016/j.annder.2019.10.027
PMID: 31812364 DOI: 10.1016/j.annder.2019.10.027
94

2019

Novembre 2019
«Impact of tobacco smoking upon disease risk, activity and therapeutic response in systemic lupus erythematosus: A systematic review and meta-analysis. »
Parisis D, Bernier C, Chasset F, Arnaud L.
Autoimmun Rev. 2019 Nov;18(11):102393. doi: 10.1016/j.autrev.2019.102393. Epub 2019 Sep 11. PMID: 31520802.
https://doi.org/10.1016/j.autrev.2019.102393
PMID: 31520802 DOI: 10.1016/j.autrev.2019.102393
96

Juillet 2019
« Current Concepts and Future Approaches in the Treatment of Cutaneous Lupus Erythematosus: A Comprehensive Review. »
Chasset F, Francès C.
Drugs. 2019 Jul;79(11):1199-1215. doi: 10.1007/s40265-019-01151-8. PMID: 31228033.
https://doi.org/10.1007/s40265-019-01151-8
PMID: 31228033 DOI: 10.1007/s40265-019-01151-8
98

Juillet 2019
« Advances in the treatment of systemic lupus erythematosus: From back to the future, to the future and beyond. »
Felten R, Scher F, Sibilia J, Chasset F, Arnaud L.
Joint Bone Spine. 2019 Jul;86(4):429-436. doi: 10.1016/j.jbspin.2018.09.004. Epub 2018 Sep 19. PMID: 30243784.
https://doi.org/10.1016/j.jbspin.2018.09.004
PMID: 30243784 DOI: 10.1016/j.jbspin.2018.09.004
113

Mai 2019
«Spotlight on anifrolumab and its potential for the treatment of moderate-to-severe systemic lupus erythematosus: evidence to date. »
Felten R, Scher F, Sagez F, Chasset F, Arnaud L.
Drug Des Devel Ther. 2019 May 8;13:1535-1543. doi: 10.2147/DDDT.S170969. PMID: 31190735; PMCID: PMC6514126.
https://doi.org/10.2147/dddt.s170969
http://www.ncbi.nlm.nih.gov/pmc/articles/pmc6514126/
PMID: 31190735 PMCID: PMC6514126 DOI: 10.2147/DDDT.S170969
100

Avril 2019
« Drug-induced systemic lupus: revisiting the ever-changing spectrum of the disease using the WHO pharmacovigilance database. »
Arnaud L, Mertz P, Gavand PE, Martin T, Chasset F, Tebacher-Alt M, Lambert A, Muller C, Sibilia J, Lebrun-Vignes B, Salem JE.
Ann Rheum Dis. 2019 Apr;78(4):504-508. doi:10.1136/annrheumdis-2018-214598. Epub 2019 Feb 4. PMID: 30793701.
https://doi.org/10.1136/annrheumdis-2018-214598
PMID: 30793701 DOI: 10.1136/annrheumdis-2018-214598
107

Mars 2019
« Rare diseases that mimic Systemic Lupus Erythematosus (Lupus mimickers) »
Chasset F, Richez C, Martin T, Belot A, Korganow AS, Arnaud L.
Joint Bone Spine. 2019 Mar;86(2):165-171. doi: 10.1016/j.jbspin.2018.10.007. Epub 2018 Oct 26. PMID: 30837156.
https://doi.org/10.1016/j.jbspin.2018.10.007
PMID: 30837156 DOI: 10.1016/j.jbspin.2018.10.007
106

Mars 2019
«Cutaneous lupus with Kikuchi disease-like inflammatory pattern associated with
myelodysplastic syndrome. »
Delplanque M, Chasset F, Hirsch P, Malard F, Ditchi Y, Fain O, Mekinian A.
Rheumatology (Oxford). 2019 Mar 1;58(3):554-556. doi:10.1093/rheumatology/key413. PMID: 30590766.
https://doi.org/10.1093/rheumatology/key413
PMID: 30590766 DOI: 10.1093/rheumatology/key413
108

Février 2019
« Advances in Cutaneous Lupus Erythematosus and Dermatomyositis: A Report from the 4th International. Conference on Cutaneous Lupus Erythematosus-An Ongoing Need for International Consensus and Collaborations. »
Concha JSS, Patsatsi A, Marshak-Rothstein A, Liu ML, Sinha AA, Lee LA, Merola JF, Jabbari A, Gudjonsson JE, Chasset F, Jarrett P, Chong B, Arkin L, Fernandez AP, Caproni M, Greenberg SA, Kim HJ, Pearson DR, Femia A, Vleugels RA, Fiorentino D, Fujimoto M, Wenzel J, Werth VP.
J Invest Dermatol. 2019 Feb;139(2):270-276. doi: 10.1016/j.jid.2018.08.017. Epub 2018 Sep 19. PMID: 30243657; PMCID: PMC6394859.
https://doi.org/10.1016/j.jid.2018.08.017
http://www.ncbi.nlm.nih.gov/pmc/articles/pmc6394859/
PMID: 30243657 PMCID: PMC6394859 DOI: 10.1016/j.jid.2018.08.017
114

2018

Aout 2018
«The 2018 pipeline of targeted therapies under clinical development for
Systemic Lupus Erythematosus: a systematic review of trials »
118: Felten R, Dervovic E, Chasset F, Gottenberg JE, Sibilia J, Scher F, Arnaud L.
Autoimmun Rev. 2018 Aug;17(8):781-790. doi: 10.1016/j.autrev.2018.02.011. Epub 2018 Jun 6. PMID: 29885544.
https://doi.org/10.1016/j.autrev.2018.02.011
PMID: 29885544 DOI: 10.1016/j.autrev.2018.02.011
118

Juillet 2018
« Risk of thromboembolic events in patients treated with thalidomide for cutaneous lupus erythematosus: A multicenter retrospective study. »
Cesbron E, Bessis D, Jachiet M, Lipsker D, Cordel N, Bouaziz JD, Bagot M, Arnaud L, Barbaud A, Francès C, Chasset F; Study Group of Systemic Diseases in Dermatology (Étude des Maladies Systémiques en Dermatologie).
J Am Acad Dermatol. 2018 Jul;79(1):162-165. doi: 10.1016/j.jaad.2018.02.049. Epub 2018 Mar 1. PMID: 29496481.
https://doi.org/10.1016/j.jaad.2018.02.049
PMID: 29496481 DOI: 10.1016/j.jaad.2018.02.049
125

Juillet 2018
«Prevalence of Pruritus in Cutaneous Lupus Erythematosus: Brief Report of a Multicenter, Multinational Cross-Sectional Study. »
116: Samotij D, Szczęch J, Kushner CJ, Mowla MR, Dańczak-Pazdrowska A, Antiga E, Chasset F, Furukawa F, Hasegawa M, Hashizume H, Islam A, Ikeda T, Lesiak A, Polańska A, Misery L, Szepietowski JC, Tsuruta D, Adamski Z, Werth VP, Reich ABiomed Res Int. 2018 Jul 25;2018:3491798. doi: 10.1155/2018/3491798. PMID: 30148164; PMCID: PMC6083500.
https://doi.org/10.1155/2018/3491798
http://www.ncbi.nlm.nih.gov/pmc/articles/pmc6083500/
PMID: 30148164 PMCID: PMC6083500 DOI: 10.1155/2018/3491798
116

Avril 2018
« Lupus érythémateux disséminé. Syndrome des anti-phospholipides [Systemic lupus erythematosus. Antiphospholipid syndrome]. »
Fain O, Chasset F, Adedjouma A, Mekinian A.
Rev Prat. 2018 Apr;68(4):e165-e175. French. PMID: 30869406.
PAS DE LIEN
104

Février 2018
« Efficacy and tolerance profile of thalidomide in cutaneous lupus erythematosus: A systematic review and meta-analysis. »
Chasset F, Tounsi T, Cesbron E, Barbaud A, Francès C, Arnaud L.
J Am Acad Dermatol. 2018 Feb;78(2):342-350.e4. doi: 10.1016/j.jaad.2017.09.059. Epub 2017 Oct 5. PMID: 28989111.
https://doi.org/10.1016/j.jaad.2017.09.059
PMID: 28989111 DOI: 10.1016/j.jaad.2017.09.059
130

Janvier 2018
« Targeting interferons and their pathways in systemic lupus erythematosus. »
128: Chasset F, Arnaud L.
Autoimmun Rev. 2018 Jan;17(1):44-52. doi: 10.1016/j.autrev.2017.11.009. Epub 2017 Nov 4. PMID: 29108825.
https://doi.org/10.1016/j.autrev.2017.11.009
PMID: 29108825 DOI: 10.1016/j.autrev.2017.11.009
128

Janvier 2018
« Changing antimalarial agents after inefficacy or intolerance in patients with cutaneous lupus erythematosus: A multicenter observational study. »
Chasset F, Arnaud L, Jachiet M, Monfort JB, Bouaziz JD, Cordoliani F, Bagot
M, Barbaud A, Francès C.
J Am Acad Dermatol. 2018 Jan;78(1):107-114.e1. doi: 10.1016/j.jaad.2017.08.045. Epub 2017 Oct 20. PMID: 29061479.
https://doi.org/10.1016/j.jaad.2017.08.045
PMID: 29061479 DOI: 10.1016/j.jaad.2017.08.045
129

2017

Juillet 2017
« Efficacy and comparison of antimalarials in cutaneous lupus erythematosus subtypes: a
systematic review and meta-analysis. »
Chasset F, Bouaziz JD, Costedoat-Chalumeau N, Francès C, Arnaud L.
Br J Dermatol. 2017 Jul;177(1):188-196. doi: 10.1111/bjd.15312. Epub 2017 May 5. PMID: 28112801.
https://doi.org/10.1111/bjd.15312
PMID: 28112801 DOI: 10.1111/bjd.15312
135

2016

Juin 2016
« Lenalidomide for refractory chronic and subacute cutaneous lupus erythematosus:
16 patients. »
Fennira F, Chasset F, Soubrier M, Cordel N, Petit A, Francès C.
J Am Acad Dermatol. 2016 Jun;74(6):1248-51. doi: 10.1016/j.jaad.2016.01.054. PMID: 27185425.
https://doi.org/10.1016/j.jaad.2016.01.054
PMID: 27185425 DOI: 10.1016/j.jaad.2016.01.054
138

Avril 2016
« The effect of increasing the dose of hydroxychloroquine (HCQ) in patients with refractory cutaneous lupus erythematosus (CLE): An open-label prospective pilot study. »
Chasset F, Arnaud L, Costedoat-Chalumeau N, Zahr N, Bessis D, Francès C.
J Am Acad Dermatol. 2016 Apr;74(4):693-9.e3. doi: 10.1016/j.jaad.2015.09.064. Epub 2016 Feb 3. PMID: 26850655.
https://doi.org/10.1016/j.jaad.2015.09.064
PMID: 26850655 DOI: 10.1016/j.jaad.2015.09.064
140

2015

Aout 2015
«Smoking enhances Toll-like receptor-9 responsiveness and type I interferon production in plasmacytoid dendritic cells in patients with cutaneous lupus erythematosus. »
Chasset F, Francès C, Arnaud L.
J Am Acad Dermatol. 2015 Aug;73(2):e81. doi: 10.1016/j.jaad.2015.05.023. PMID: 26184009.
https://doi.org/10.1016/j.jaad.2015.05.023
PMID: 26184009 DOI: 10.1016/j.jaad.2015.05.023
145

Aout 2015
« Influence of smoking on the efficacy of antimalarials in cutaneous lupus: a meta-analysis of the
literature. »
Chasset F, Francès C, Barete S, Amoura Z, Arnaud L.
J Am Acad Dermatol. 2015 Apr;72(4):634-9. doi: 10.1016/j.jaad.2014.12.025. Epub 2015 Jan 30. Erratum in: J Am Acad Dermatol. 2015 Aug;73(2):353. PMID: 25648824.
https://doi.org/10.1016/j.jaad.2014.12.025
PMID: 25648824 DOI: 10.1016/j.jaad.2014.12.025
147

• Etude 230LE301
• Etude Aster

2024

En cours de publication
Clinical and Experimental Rheumatology Via Santa Maria 31 – 56126 PISA
« Gastrointestinal disorders in systemic sclerosis : cluster analysis and prognosis from a french propective cohort »
Authors (list all authors in order of authorship : C Mollière, A.F. Guédon, N.Kapel, F. de Vassoigne, F. Graiess, P. Sennet, C. Cacciatore, C. Mc Avoy, O. FAIN, S. Rivière, A. Mekinian
Manuscript number : CER 17841 24

En cours de publication
Rheumatology RHE-24-1162.R1: « The digital ulcers of systemic sclerosis are strongly associated with digital arterial disease ».

22 Janvier 2024
“Nailfold dermoscopy predicts the absence of a capillaroscopy sclerodermic pattern: The multicentre, prospective VASCUL-R trial”
Monfort JB, Klejtman T, Lazareth I, Kottler D, Blaise S, Imbert B, Chaby G, Lok C, Maillard H, Beneton N, Journet-Tollhupp J, Goujon E, Jacquin A, Tella E, Mboup B, Vicaut E, Senet P.. J Eur Acad Dermatol Venereol.
2024 22. doi: 10.1111/jdv.19803.
PMID: 38251814 DOI: 10.1111/jdv.19803

2023

1er septembre 2023
«Systemic sclerosis-associated interstitial lung disease in theEUSTAR database: analysis by region. »
Lescoat A, Huscher D, Schoof N, Airò P, de Vries-Bouwstra J, Riemekasten G, Hachulla E, Doria A, Rosato E, Hunzelmann N, Montecucco C, Gabrielli A,nHoffmann-Vold AM, Distler O, Ben Shimol J, Cutolo M, Allanore Y; EUSTAR collaborators.
Rheumatology (Oxford). 2023 Jun 1;62(6):2178-2188. doi: 10.1093/rheumatology/keac576. Erratum in: Rheumatology (Oxford). 2023 Sep 1;62(9):3219-3220. PMID: 36222557.
https://doi.org/10.1093/rheumatology/kead247
PMID: 37295958 DOI: 10.1093/rheumatology/kead247
10

Aout 2023
« Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR Database. »
Lescoat A, Huang S, Carreira PE, Siegert E, de Vries-Bouwstra J, Distler JHW, Smith V, Del Galdo F, Anic B, Damjanov N, Rednic S, Ribi C, Bancel DF, Hoffmann-Vold AM, Gabrielli A, Distler O, Khanna D, Allanore Y; EUSTAR collaborators.
JAMA Dermatol. 2023 Aug 1;159(8):837-847. doi: 10.1001/jamadermatol.2023.1729. PMID: 37378994; PMCID: PMC10308295.
https://doi.org/10.1001/jamadermatol.2023.1729
PMID: 37378994 PMCID: PMC10308295 (available on 2024-06-28) DOI: 10.1001/jamadermatol.2023.1729
8

1er juin 2023
« Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by region. »
Lescoat A, Huscher D, Schoof N, Airò P, de Vries-Bouwstra J, Riemekasten G, Hachulla E, Doria A, Rosato E, Hunzelmann N, Montecucco C, Gabrielli A, Hoffmann-Vold AM, Distler O, Ben Shimol J, Cutolo M, Allanore Y; EUSTAR collaborators.
Rheumatology (Oxford). 2023 Jun 1;62(6):2178-2188.
PMID: 36222557 DOI: 10.1093/rheumatology/keac576

Mars 2023
« Efficacy and Safety of Botulinum Toxin in Adults with Raynaud’s Phenomenon Secondary to Systemic Sclerosis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study. »
Senet P, Maillard H, Diot E, Lazareth I, Blaise S, Arnault JP, Pistorius MA, Boulon C, Cogrel O, Warzocha U, Rivière S, Malloizel-Delaunay J, Servettaz A, Sassolas B, Viguier M, Monfort JB, Janique S, Vicaut E; BRASS collaborators.
Arthritis Rheumatol. 2023 Mar;75(3):459-467. doi:10.1002/art.42342. Epub 2022 Dec 14. PMID: 36066501.
https://doi.org/10.1002/art.42342
PMID: 36066501 DOI: 10.1002/art.42342
13

Mars 2023
“Reply”
Senet P, Vicaut E; BRASS collaborators.. Arthritis Rheumatol.
2023 Mar;75(3):486-487
No abstract available
PMID: 36209510 DOI: 10.1002/art.42377

2022

Mai 2022
« Finger Systolic Blood Pressure Index Measurement: A Useful Tool for the Evaluation of Arterial Disease in Patients With Systemic Sclerosis. »
Blaise S, Boulon C, Mangin M, Senet P, Lazareth I, Imbert B, Lapebie FX, Lacroix P, Constans J, Carpentier P. Arthritis Care Res (Hoboken). 2022 May;74(5):828-832. doi: 10.1002/acr.24527. Epub 2022 Mar 17. PMID: 33278327.
https://doi.org/10.1002/acr.24527
MID: 33278327 DOI: 10.1002/acr.24527
29

2021

Septembre 2021
« Systemic sclerosis is associated with lower limb vascular stiffness and microvascular impairment: results from a prospective study. »
Cassius C, Seta V, Monfort JB, Baudot NA, Rivière S, Mekinian A, Frances C, Barbaud A, Senet P.
Clin Rheumatol. 2021 Sep;40(9):3679-3686. doi: 10.1007/s10067-021-05672-0. Epub 2021 Mar 6. PMID: 33674989.
https://doi.org/10.1007/s10067-021-05672-0
PMID: 33674989 DOI: 10.1007/s10067-021-05672-0
25

2019

Juillet 2019
« Correlation between capillaroscopic classifications and severity in systemic sclerosis: results from SCLEROCAP study at inclusion. »
Boulon C, Aiouaz S, Blaise S, Mangin M, Decamps-Le Chevoir J, Senet P, Lazareth I, Baudot N, Tribout L, Imbert B, Lapebie FX, Lacroix P, Truchetet ME, Seneschal J, Solanilla A, Skopinski S, Lazaro E, Quéré I, Pistorius MA, Le Hello C, Perez P, Carpentier P, Constans J. Clin Exp Rheumatol. 2019 Jul-Aug;37 Suppl 119(4):63-68. Epub 2019 May 30. PMID: 31172926.
41

Avril 2019
« Circulating follicular helper T cells are increased in systemic sclerosis and promote plasmablast differentiation through the IL-21 pathway which can be inhibited by ruxolitinib »
Ricard L, Jachiet V, Malard F, Ye Y, Stocker N, Rivière S, Senet P, Monfort JB, Fain O, Mohty M, Gaugler B, Mekinian A.
Ann Rheum Dis. 2019 Apr;78(4):539-550. doi: 10.1136/annrheumdis-2018-214382. Epub 2019 Feb 13. PMID: 30760472.
https://doi.org/10.1136/annrheumdis-2018-214382
PMID: 30760472 DOI: 10.1136/annrheumdis-2018-214382
45

2018

Juillet 2018
« Lower-limb Ulcers in Systemic Sclerosis: A Multicentre Retrospective Case-control Study. »
Bohelay G, Blaise S, Levy P, Claeys A, Baudot N, Cuny JF, Maillard H, Granel-Brocard F, Boyé T, Lok C, Bénéton N, Francès C, Senet PActa Derm Venereol. 2018 Jul 11;98(7):677-682. doi: 10.2340/00015555-2939. PMID: 29648670.
https://doi.org/10.2340/00015555-2939
PMID: 29648670 DOI: 10.2340/00015555-2939
47

2017

Octobre 2017
« Reproducibility of capillaroscopic classifications of systemic sclerosis: results from the SCLEROCAP study »
Boulon C, Devos S, Mangin M, Decamps-Le Chevoir J, Senet P, Lazareth I, Baudot N, Tribout L, Imbert B, Blaise S, Sintes P, Lapebie FX, Lacroix P, Truchetet ME, Seneschal J, Solanilla A, Skopinski S, Lazaro E, Quéré I, Pistorius MA, Le Hello C, Perez P, Carpentier P, Constans J.
Rheumatology (Oxford). 2017 Oct 1;56(10):1713-1720. doi: 10.1093/rheumatology/kex246. PMID: 28957554.
https://doi.org/10.1093/rheumatology/kex246
PMID: 28957554 DOI: 10.1093/rheumatology/kex246
52

Avril 2017
« Intravenous immunoglobulins in systemic sclerosis: Data from a French nationwide cohort of 46 patients and review of the literature. »
Sanges S, Rivière S, Mekinian A, Martin T, Le Quellec A, Chatelus E, Lescoat A, Jego P, Cazalets C, Quéméneur T, Le Gouellec N, Senet P, Francès C, Deroux A, Imbert B, Fain O, Boukari L, Sené T, Deligny C, Mathian A, Agard C, Pugnet G, Speca S, Dubucquoi S, Hatron PY, Hachulla É, Launay D.
Autoimmun Rev. 2017 Apr;16(4):377-384. doi: 10.1016/j.autrev.2017.02.008. Epub 2017 Feb 13. PMID: 28232167.
https://doi.org/10.1016/j.autrev.2017.02.008
PMID: 28232167 DOI: 10.1016/j.autrev.2017.02.008
53

2014

Décembre 2014
« Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis. »
Minier T, Guiducci S, Bellando-Randone S, Bruni C, Lepri G, Czirják L, Distler O, Walker UA, Fransen J, Allanore Y, Denton C, Cutolo M, Tyndall A, Müller-Ladner U, Matucci-Cerinic M; EUSTAR co-workers; EUSTAR co-workers.
Ann Rheum Dis. 2014 Dec;73(12):2087-93. doi: 10.1136/annrheumdis-2013-203716. Epub 2013 Aug 12. PMID: 23940211.
https://doi.org/10.1136/annrheumdis-2013-203716
PMID: 23940211 DOI: 10.1136/annrheumdis-2013-203716
62

2013

Avril 2013
« Correlations between angiogenic factors and capillaroscopic patterns in systemic sclerosis. »
Avouac J, Vallucci M, Smith V, Senet P, Ruiz B, Sulli A, Pizzorni C, Frances C, Chiocchia G, Cutolo M, Allanore Y.
Arthritis Res Ther. 2013 Apr 19;15(2):R55. doi: 10.1186/ar4217. PMID: 23601622; PMCID: PMC4060197.
https://doi.org/10.1186/ar4217
http://www.ncbi.nlm.nih.gov/pmc/articles/pmc4060197/
PMID: 23601622 PMCID: PMC4060197 DOI: 10.1186/ar4217
64

• Etude DAISY

•   PNDS
•   Synthèse du PNDS à destination du médecin traitant
•   Argumentaire

•   PNDS
•   Synthèse du PNDS à destination du médecin traitant

•   PNDS
•   Synthèse du PNDS à destination du médecin traitant